The Schmidt Firm, LLP

RSD & CRPS Lawsuits

The Schmidt FIrm, LLP — Tue, 09 Mar 2010 22:17:39 +0000

Reflex Sympathetic Dystrophy (RSD) or Complex Regional Pain Syndrome (CRPS) is a chronic and often disabling condition that can be caused by the negligence of another.

What You Can Do & How We Can Help

The Schmidt Firm, LLP is currently accepting RSD/CRPS claims in all 50 states. If you or somebody you know has had an injury and subsequently been diagnosed with RSD/CRPS, you should contact our firm immediately for a free case consultation. Please click here to contact our Personal Injury Litigation Group or call toll free 24 hours a day at (866) 920-0753.

More RSD/CRPS Information

Millions of Americans suffer from Reflex Sympathetic Dystrophy (RSD) or Complex Regional Pain Syndrome (CRPS), a chronic and progressive neurological syndrome. RSD/CRPS develops after an injury or trauma to the body, such as a broken bone, fall or car accident. People who have RSD/CRPS experience severe pain and other symptoms such as changes in skin temperature, color, and sensitivity, as well as swelling and increased hair and nail growth. RSD/CRPS generally affects the arms, legs, hands, and feet, but can occur in any part of the body. The symptoms of RSD/CRPS may worsen over time and can be disabling.

Diagnosing RSD/CRPS is difficult and involves a thorough medical history along with a physical exam and other testing. If the injury that led to RSD/CRPS was caused by the negligence of another, you may have the right to recover. Due to the limited time in which to recover under the law and the difficulty in diagnosing RSD/CRPS, it is important that you speak with your doctor immediately if you think you may have RSD/CRPS.

Do I Have a RSD/CRPS Lawsuit?

The Schmidt Firm, LLP is currently accepting RSD/CRPS claims in all 50 states. If you or somebody you know has suffered an injury and subsequently been diagnosed with RSD/CRPS, you should contact our Personal Injury Litigation Group or call toll free 24 hours a day at (866) 920-0753.

Metal on Metal Hip Implant Lawsuits

The Schmidt FIrm, LLP — Tue, 09 Mar 2010 22:14:16 +0000

Metal on Metal Hip Implants Linked to Side Effects

Metal on metal hip replacements have recently been associated with loss of bone, inflammatory reactions, death of surrounding tissue and the need for early replacement.

What You Can Do & How We Can Help

The Schmidt Firm, LLP is currently accepting metal on metal hip implant side effect claims in all 50 states. If you or somebody you know had a metal on metal implant and subsequently suffered loss of bone, an inflammatory reaction, death of surrounding tissue or early replacement, you should contact our firm immediately for a free case consultation. Please click here to contact our Product Liability Litigation Group or call toll free 24 hours a day at (866) 920-0753.

More Metal on Metal Hip Implant Information

The New York Times recently reported that metal on metal hip implants can have serious and sometimes lifelong complications. These implants were developed to be more enduring than previous implants but have been found to cause loss of bone, inflammatory reactions, death of surrounding tissue and even the need for early replacement. Some of the complications are believed to be caused by metal pieces being shed into the body. The article reported that the metal on metal implants have been used in about one-third of the approximately 250,000 hip replacements performed each year. Another recent article in the Journal of Arthroplasty urged doctors to use the metal-on-metal implants with “great caution, if at all.”

Several companies manufacture metal on metal hip implants and according to the New York Times article, some experts believe that “in a rush to meet the demand for metal-on-metal devices, [manufacturers] marketed some poorly designed implants.”

Metal on Metal Hip Implant Side Effects

Metal on Metal hip Implants have been linked to the following side effects:

Loss of bone
Inflammatory reactions causing pain
Early replacement
Death of surrounding tissue

Do I Have a Metal on Metal Hip Implant Lawsuit?

Orlistat (Alli & Xenical) Lawsuit

The Schmidt FIrm, LLP — Tue, 25 Aug 2009 18:17:33 +0000

Recently, the U.S. Food & Drug Administration (FDA) issued a public health warning regarding the popular prescription and over-the-counter (OTC) weight loss drugs Alli and Xenical. Both drugs contain Orlistat, which has recently been linked to an increased risk of liver problems including liver injury, damage and failure.

What You Can Do & How We Can Help

Xenical Side Effects & Lawsuit Information

The Schmidt Firm, LLP is currently accepting Orlistat side effect claims in all 50 states. If you or somebody you know has taken Orlistat, Alli or Xenical and subsequently been diagnosed with a liver injury or other serious side effect, you should contact our firm immediately for a free case consultation. Please click here to contact our Dangerous Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.

What’s the problem with weight loss drugs containing Orlistat?

The FDA is reviewing new safety information regarding reports of liver-related adverse events in patients taking orlistat. Orlistat is marketed in the United States as a prescription product, Xenical, and as an over-the-counter (OTC) product, Alli.

Xenical (orlistat 120mg) was approved as a prescription product by FDA in 1999 for obesity management in conjunction with a reduced caloric diet, and to reduce the risk of regaining weight after prior weight loss.

Alli Side Effects & Lawsuit Information

In 2007, Alli (orlistat 60mg) was approved for OTC use for weight loss in overweight adults, 18 years and older, in conjunction with a reduced-calorie and low-fat diet. Currently, orlistat is approved for marketing in approximately 100 countries. In January 2009, a nonprescription version of orlistat was approved for sale in the European Union.

Between 1999 and October 2008, 32 reports of serious liver injury, including 6 cases of liver failure, in patients using orlistat were submitted to FDA’s Adverse Event Reporting System. Thirty of the 32 reports occurred outside the United States. The most commonly reported adverse events described in the 32 reports of serious liver injury were jaundice (yellowing of the skin or whites of the eyes), weakness, and abdominal pain. Hospitalization was reported in 27 of the 32 cases.

In addition to the 32 reported cases, this issue was discussed at the CDER Drug Safety Oversight Board in April 2009, and FDA is reviewing other data on suspected cases of liver injury submitted by the manufacturers of orlistat. FDA’s analysis of these data is ongoing and no definite association between liver injury and orlistat has been established at this time.

Do I Have an Orlistat, Alli or Xenical Lawsuit?

The Schmidt Firm, LLP is currently accepting Orlistat side effect claims in all 50 states. If you or somebody you know has taken Orlistat, Alli or Xenical and subsequently been diagnosed with a liver injury or other serious side effect, you should contact our firm immediately for a free case consultation. Please use the form below to contact our Dangerous Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.

U.S. Marshals Seize Drug Products Manufactured by Caraco Pharmaceutical Laboratories Ltd.

The Schmidt FIrm, LLP — Thu, 25 Jun 2009 21:41:51 +0000

On June 25, 2009 U.S. Marshals, at the request of the Food and Drug Administration, seized drug products manufactured by Caraco Pharmaceutical Laboratories Ltd. (Caraco), at the company’s Michigan facilities in Detroit, Farmington Hills, and Wixom. The seizure also includes ingredients held at these same facilities. “The FDA is committed to taking enforcement action against firms that do not manufacture drugs in accordance with our good manufacturing practice requirements,” said Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research. “Compliance with these standards prevents harm to the public.”

This action follows Caraco’s continued failure to meet the FDA’s current Good Manufacturing Practice (cGMP) requirements, which assure the quality of manufactured drugs. Through this seizure, the FDA seeks to immediately stop the firm from further distributing drugs until there is assurance that the firm complies with good manufacturing requirements.

Since January 2009, Caraco has initiated voluntary recalls of drug products to protect the public from potentially defective medications. The recalls involved manufacturing defects, including oversized tablets and possible formulation error.

The FDA has determined that the seizure of Caraco’s drugs may create a shortage of one product, choline magnesium trisalicylate oral tablets, which are commonly used as pain relievers. The FDA recommends in the event of a shortage, that health care providers consider alternative treatments that are safe and effective. Consumers and health care providers who are unable to obtain any of Caraco’s products should contact the FDA Drug Shortage Program by e-mail at drugshortages@fda.hhs.gov, or by telephone at 888-463-6332 or 301-796-3400.

The FDA’s most recent inspection of Caraco, completed in May 2009, found unresolved violations of cGMP requirements. Today’s seizure is intended to lead to major changes at Caraco’s facilities.

If the FDA identifies further significant problems, which pose risks to patient safety with any Caraco drug products on the market, the agency will take appropriate additional regulatory action and immediately notify the public.

“The FDA will continue to take swift, aggressive enforcement action when firms are identified as being in violation of our manufacturing requirements,” said Michael Chappell, FDA acting associate commissioner for regulatory affairs.

Seizure of drug products is an effective remedy when there is evidence of continued poor compliance with cGMPs. Following a drug product seizure, companies often agree to a wide range of changes and improvements to their drug manufacturing practices at their facilities.

What You Can Do & How We Can Help

The Schmidt Firm, LLP is currently accepting Caraco drug side effect and overdose claims in all 50 states. If you or somebody you know has taken a drug manufactured by Caraco and subsequently suffered from an adverse event, you should contact our firm immediately for a free case consultation. Please click here to contact our Dangerous Drug Litigation Group, use the form below or call toll free 24 hours a day at (866) 920-0753.

Caraco Drug Recall Lawsuit

The Schmidt FIrm, LLP — Thu, 25 Jun 2009 21:38:55 +0000

Caraco Pharmaceutical Laboratories Ltd. (Caraco) has recalled numerous drugs at the request of the U.S. Food & Drug Administration because of the companies failure to meet the FDA’s current Good Manufacturing Practice (cGMP) requirements. The FDA originally learned that Caraco was manufacturing double thickness pills, which may lead to patients to unintentionally suffer from an overdose and/or death.

What You Can Do & How We Can Help

The Schmidt Firm, LLP is currently accepting Caraco drug side effect and overdose claims in all 50 states. If you or somebody you know has taken a drug manufactured by Caraco and subsequently suffered from an adverse event, you should contact our firm immediately for a free case consultation. Please click here to contact our Dangerous Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.

Caraco Recall List

Allopurinol Tablets
Amlodipine Tablets
Atenolol Tablets
Baclofen Tablets
Carvedilol Tablets
Cetirizine Tablets
Cetirizine IR Tablets
Choline Magnesium Trisalicylate Tablets
Citalopram HBR Tablets
Clonazepam Tablets
Clozapine Tablets
Digoxin Tablets
Flurbiprofen Tablets
Fluvoxamine Maleate Tablets
Glipizide Tablets
Glipizide/Metformin Tablets
Hydrochlorothiazide Tablets
Meloxicam Tablets
Meperidine HCl C-II Tablets
Metformin Tablets
Methimazole Tablets
Metoprolol Tartrate Tablets
Midrin Capsules
Mirtazapine Tablets
Oxaprozin Tablets
Paromomycin Sulfate, USP Capsules
Paroxetine Tablets
Phentermine HCl Tablets
Ticlopidine HCl Tablets
Tizanidine HCl Tablets
Tramadol HCl Tablets
Tramadol HCl/Acetaminophen Tablets
Zolpidem Tartrate Tablets

Do I Have a Caraco Drug Recall Lawsuit?

Again, if you or somebody you know has taken a drug manufactured by Caraco and subsequently suffered from an adverse event, you should contact our firm immediately for a free case consultation. Please click here to contact our Dangerous Drug Litigation Group, use the form below or call toll free 24 hours a day at (866) 920-0753.

San Antonio CERVELAT Sausage Recall

The Schmidt FIrm, LLP — Thu, 25 Jun 2009 17:26:19 +0000

CERVELAT Sausage Recall

On June 24, 2009 the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) in association with Laxson Provision Company announced a recall of approximately 350 pounds of cervelat sausage products. The sausage recall was initiated due to a grocery store complaint that the sausage may be undercooked.

CERVELAT Sausage Recall List

3 - 3.5-pound vacuum packed chubs of “Ready to Eat Laxson Quality Meat Products CERVELAT.” Each label bears the lot number “8952″ and the date of production “Produced June 0809″ as well as the establishment number “EST-13342″ inside the USDA mark of inspection.

Each case contains twelve (12) 3 - 3.5-pound chubs per box, which can be identified by the lot number “8952″ and the item number “12053.” The product was produced on June 8, 2009 and packaged on June 9, 2009. The product distribution is limited to small grocers in San Antonio, Texas.

Do I Have a Sausage Recall Lawsuit?

If you or somebody you know has been sickened by CERVELAT sausage, you should contact us immediately. You may be entitled to compensation for your injuries and the food poisoning attorneys and lawyers at our law firm can help.

JBS Swift Beef Company Beef Recall

The Schmidt FIrm, LLP — Thu, 25 Jun 2009 17:18:23 +0000

JBS Swift Beef Company Recalls Approx 41,000 Pounds of Beef Products

On June 24, 2009 JBS Swift Beef Company in association with the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced a nationwide recall of 41,280 pounds of beef products because they may be contaminated with E. coli O157:H7.

E. coli O157:H7 is a potentially deadly bacterium that can cause bloody diarrhea, dehydration, and in the most severe cases, kidney failure. The very young, seniors and persons with weak immune systems are the most susceptible to foodborne illness. Individuals concerned about an illness should contact a physician.

If you or somebody you know has been sickened with E. coli O157:H7 by any of the beef products listed on the recall list below, you should contact us immediately. You may be entitled to compensation for your injuries and the food poisoning attorneys and lawyers at our law firm can help.

JBS Swift Beef Company Recall List

The products subject to recall include:

Boxes of “USDA CHOICE OR HIGHER, Bnls Beef Bottom Sirloin, Butt Ball Tip 2/DN S/T.” Each box bears the establishment number “EST. 969″ inside the USDA mark of inspection, identifying package dates of “042109″ or “042209″ and a case code of “21852.”
Boxes of “USDA CHOICE OR HIGHER, Bnls Beef Bottom Sirloin, Butt Ball Tip 2/UP S/T.” Each box bears the establishment number “EST. 969″ inside the USDA mark of inspection, identifying package dates of “042109″ or “042209″ and a case code of “21853.”
Boxes of “Swift, Bnls Beef Bottom Sirloin, Butt Ball Tip 2/DN S/T.” Each box bears the establishment number “EST. 969″ inside the USDA mark of inspection, identifying package dates of “042109″ or “042209″ and a case code of “31852.”
Boxes of “Bnls Beef Bottom Sirloin, Butt Ball Tip 2/UP S/T.” Each box bears the establishment number “EST. 969″ inside the USDA mark of inspection, identifying package dates of “042109″ or “042209″ and a case code of “31853.”
Boxes of “Swift, USDA SELECT, Bnls Beef Bottom Sirloin, Butt Ball Tip 2/DN S/T.” Each box bears the establishment number “EST. 969″ inside the USDA mark of inspection, identifying package dates of “042109″ or “042209″ and a case code of “33852.”
Boxes of “USDA SELECT, Bnls Beef Bottom Sirloin, Butt Ball Tip 2/UP S/T.” Each box bears the establishment number “EST. 969″ inside the USDA mark of inspection, identifying package dates of “042109″ or “042209″ and a case code of “33853.”
Boxes of “BLACK ANGUS, Swift Premium, BEEF, USDA CHOICE OR HIGHER, Bnls Beef Bottom Sirloin, Butt Ball Tip 2/UP S/T.” Each box bears the establishment number “EST. 969″ inside the USDA mark of inspection, identifying package dates of “042109″ or “042209″ and a case code of “41853.”
Boxes of “BLACK ANGUS, Swift Premium, BEEF, USDA CHOICE OR HIGHER, Bnls Beef Bottom Sirloin, Butt Ball Tip 2/UP S/T.” Each box bears the establishment number “EST. 969″ inside the USDA mark of inspection, identifying package dates of “042109″ or “042209″ and a case code of “41853.”
Boxes of “Bnls Beef Bottom Sirloin, Butt Ball Tip 2/DN S/T.” Each box bears the establishment number “EST. 969″ inside the USDA mark of inspection, an identifying package date of “042109″ and a case code of “79852.”
Boxes of “Bnls Beef Bottom Sirloin, Butt Ball Tip 2/UP S/T.” Each box bears the establishment number “EST. 969″ inside the USDA mark of inspection, an identifying package date of “042109″ and a case code of “79853.”
Boxes of “USDA CHOICE OR HIGHER, Bnls Beef Bottom Sirloin, Butt Ball Tip 2/UP S/T.” Each box bears the establishment number “EST. 969″ inside the USDA mark of inspection, identifying package dates of “042109″ or “042209″ and a case code of “90853.”

These beef products were produced on April 21 and 22, 2009, and were shipped to distributors and retail establishments in Arizona, California, Colorado, Florida, Illinois, Michigan, Minnesota, Nebraska, Oregon, South Carolina, Tennessee, Utah and Wisconsin.

Do I Have a Beef Recall Lawsuit?

Again, if you or somebody you know has been sickened with E. coli O157:H7 by any of the beef products listed above, you should contact us immediately. You may be entitled to compensation for your injuries and the food poisoning attorneys and lawyers at our law firm can help.

Zicam® Recall: SEC & FDA Investigates Matrixx

The Schmidt FIrm, LLP — Thu, 25 Jun 2009 16:35:03 +0000

On June 24, 2009 the Associated Press (AP) reported that the U.S. Food & Drug Administration (FDA) is looking into whether Matrixx Initiatives Inc. unlawfully marketed the Zicam product and the U.S. Securities & Exchange Commission (SEC) has launched a formal investigation of Matrixx Initiatives Inc.

These investigations follow the June 16, 2009 Zicam and loss of smell warning letter from the FDA, which resulted in the company recalling a variety of Zicam products.

Matrixx has settled hundreds of lawsuits connected with Zicam in recent years, though it maintains the nasal spray does not harm users’ sense of smell.

Zicam Recall List

The following products have been recalled by Matrixx after the FDA linked them to a large number of consumer injury reports regarding the use of the products and the subsequent loss of smell, also known as Anosmia.

Zicam Cold Remedy Nasal Gel
Zicam Cold Remedy Nasal Swabs
Zicam Cold Remedy Swabs, Kids Size (a discontinued product)

Do I Have a Zicam Loss of Smell Lawsuit?

The Schmidt Firm, LLP is currently accepting Zicam induced anosmia claims in all 50 states. If you or somebody you know has taken Zicam and suffered from the loss of sense of smell, or anosmia, you should contact our firm immediately for a free case consultation. Please click here to contact our Dangerous Drug Litigation Group, use the form below or call toll free 24 hours a day at (866) 920-0753.

Medtronic Subpoenaed Over Bogus Infuse Bone Graft Study

The Schmidt FIrm, LLP — Thu, 25 Jun 2009 01:50:00 +0000

On June 23, 2009 the U.S. Attorney for Massachusetts subpoenaed the manufacturer of the Infuse Bone Graft product, Medtronic, Inc. The U.S. attorney is seeking documents related to a study by a former U.S. Army surgeon, who is accused of fabricating data regarding the Infuse Bone Graft product.

The Subpoena issued today only adds to a growing list of problems for Medtronic related to the spine product. The U.S. Food & Drug Administration (FDA) has issued safety warnings, The U.S. Department of Justice (DOJ) has begun a criminal investigation and most recently, Medtronic recently admitted to paying the aforementioned U.S. Army surgeon nearly $800,000.

Types of Medtronic Infuse Bone Graft Lawsuits We Are Handling

To understand what types of injury cases our law firm is currently accepting, you should be aware of the history of this product …

The Infuse Bone Graft product was originally approved for the use in lumbar spine procedures, however in recently filed whistleblower and separate individual injury lawsuits the company has been accused of marketing the product for use in the cervical spine (neck) procedures, which is an “off-label” use and not approved by the FDA.

“When the Infuse Bone Graft is used in an off-label procedure, it has the potential to cause life threatening injuries, complications and/or deaths,” says Michael E. Schmidt, Partner in The Schmidt Firm, LLP.

What You Can Do & How We Can Help

The Schmidt Firm, LLP is currently accepting Medtronic Infuse Bone Graft injury claims in all 50 states. If you or somebody you know has experienced complications after a procedure in which the Medtronic Infuse Bone Graft product was used, you should contact our law firm immediately for a free case evaluation. Please click here to contact our Medical Device Litigation Group or call toll free 24 hours a day at (866) 920-0753.

A Guide to Contact Lens Safety

The Schmidt FIrm, LLP — Wed, 24 Jun 2009 17:31:06 +0000

More than 30 million Americans use contact lenses contact solutions. The U.S. Food & Drug Administration (FDA) has published a guide to contact lens safety titled, “Focusing on Contact Lens Safety.” Please click on the image or link below to download a copy of the very informative FDA guide.

Download: Focusing on Contact Lens Safety (pdf)

Contact Lens Solution & Eye Infection Lawsuits

The Schmidt Firm, LLP is currently accepting claims in all 50 states for those who used AMO Complete MoisturePlus and have developed Acanthamoeba Keratitis. If you or somebody you know has used AMO Complete MoisturePlus and developed Acanthamoeba Keratitis, you should contact our firm immediately for a free case consultation. Please click here to contact our Product Liability Litigation Group, use the form below or call toll free 24 hours a day at 866-920-0753.